Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver disease
- PMID: 35710263
- DOI: 10.1183/13993003.00930-2022
Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver disease
Conflict of interest statement
Conflict of interest: Jae-Joon Yim received donations of linezolid (Zyvox) from Pfizer, Inc., and delamanid (Deltyba) from Otsuka Pharmaceutical Co. for the clinical trials for which he served as a principal investigator. All other authors report no potential conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical